|Bid||84.01 x 900|
|Ask||84.05 x 900|
|Day's Range||83.33 - 84.58|
|52 Week Range||49.70 - 87.03|
|Beta (5Y Monthly)||0.76|
|PE Ratio (TTM)||49.29|
|Forward Dividend & Yield||2.00 (2.37%)|
|Ex-Dividend Date||Jun 30, 2023|
|1y Target Est||N/A|
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
McDonald's, W.W. Grainger and Cardinal Health are included in this Analyst Blog.
Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
Banking on recent strengths, investors should place their bets on sound stocks like McDonald's (MCD), W.W. Grainger (GWW) & Cardinal Health (CAH) that are poised to scale upward along with the broader S&P 500 Index.
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
For Alcon (ALC), in terms of end market, Surgical global cataract procedure growth varies significantly by region.
Globus Medical's (GMED) REFLECT is intended to treat young children with progressive scoliosis, while preserving motion, stability and future modulated growth.
Investors are optimistic about LabCorp (LH) on strategic partnerships and upbeat guidance.
Cardinal Health, Boyd Gaming, Ford Motor, NXP Semiconductors N.V and American International are part of the Zacks Screen of the Week article.
Abbott's (ABT) latest additions to Diversity in Clinical Trials effort expand upon the alliances, awards and the emphasis on diverse participation in its own clinical trials.
Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.
Here are five stocks that meet our screening criteria - CAH, BYD, F, NXPI, AIG.
National Vision's (EYE) Q1 net revenues are positively impacted by the timing of unearned revenue.
Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.
The Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to drive the top line further.
NextGen's (NXGN) Behavioral Health Suite is expected to offer better access to care and improve patient outcomes.
Revvity's (PKI) first-quarter results reflect the impact of transition following divestment of AES business. While earnings outpace estimates, sales miss the same.
Fresenius Medical's (FMS) first-quarter revenues benefit from strong performances across all segments, especially the North America and Asia-Pacific regions. However, rising costs hurt margins.
Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q1 sales.
DaVita's (DVA) robust revenues in both segments drive its first-quarter performance.
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.
McKesson's (MCK) fiscal fourth-quarter 2023 results benefit from growth in the United States. Divestment hurt the International segment.
Despite strength in Avanos' (AVNS) Chronic Care segment, its overall first-quarter results reflect soft performances.
AMN Healthcare's (AMN) dismal results in all its segments led to a soft overall Q1 performance.
Despite higher domestic business-to-business sales and rental revenues, Inogen's (INGN) overall first-quarter results reflect soft performances.